Cleared Traditional

K053453 - HOMMED CENTRAL STATION

K053453 is the FDA 510(k) clearance for HOMMED CENTRAL STATION by Honeywell Hommed, LLC. It is a Class 2 Cardiovascular device (product code DXN) cleared through the Traditional 510(k) pathway after a 144-day FDA review.

K053453 · Honeywell Hommed, LLC · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2006
Decision
144d
Days
Class 2
Risk

K053453 is an FDA 510(k) clearance for the HOMMED CENTRAL STATION, VERSION 3.5. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Honeywell Hommed, LLC (Houston, US). The FDA issued a Cleared decision on May 5, 2006 after a review of 144 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Honeywell Hommed, LLC devices

Submission Details

510(k) Number K053453 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 12, 2005
Decision Date May 05, 2006
Days to Decision 144 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
19d slower than avg
Panel avg: 125d · This submission: 144d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 511
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K053453.
MICROLIFE AUTOMATIC BLOOD PRESSURE MONITOR, MODEL BP3AC1-1PC
K060686 · Microlife Intellectual Property GmbH · Jun 2006
CLEVER CHECK TD-3250 BLOOD GLUCOSE AND BLOOD PRESSURE MEASUREMENT SYSTEM, MODEL TD-3250
K061073 · Taidoc Technology Corporation · Jun 2006
ACON AUTOMATIC BLOOD PRESSURE MONITOR KIT, MODEL OB11-111, W/AC ADAPTER, MODEL OB11-112
K060925 · ACON Laboratories, Inc. · May 2006
HL888SF
K060835 · Health & Life Co., Ltd. · Apr 2006
FULL AUTOMATIC (NIBP) BLOOD PRESSURE MONITOR, MODEL HL168FV
K060729 · Health & Life Co., Ltd. · Apr 2006
PMP4 BP PRO BLOOD PRESSURE MONITOR
K060703 · Card Guard Scientific Survival , Ltd. · Apr 2006